Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Zealand Pharma - Transactions related to share buy-back program (week 28, 2026)
Company announcement No. 32 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 28, 2026) Copenhagen, Denmark, July 13, 2026 – Zealand Pharma A/S ('the Company' or “Zealand Pharma”) (Nasdaq: ZEAL)…
UK caves to pharma demands in Swiss trade deal - despite NHS cost fears
“The U.K. government is risking our healthcare system and the health of patients in order to reduce its ability to legislate and regulate in the interests of the public — and they're doing that in order to please the pharmaceutical…
NervGen Pharma (NASDAQ:NGEN) Now Covered by Leerink Partners
Leerink Partners assumed coverage on shares of NervGen Pharma (NASDAQ:NGEN - Get Free Report) in a report issued on Monday. The brokerage set an 'outperform' rating and a $10.00 price target on the stock. Leerink Partners' target price suggests a…
New Phase 1 Data Show VNA-318 Mechanism of Action Translates to Humans, Supporting Potential to Address Medical Needs of People with Neurodegenerative Diseases
Pharmacodynamic effects in the human brain and energy metabolism biomarker data presented at AAIC support further clinical development of VNA-318 in Alzheimer's disease LAUSANNE, Switzerland, July 13, 2026 – Vandria, a clinical-stage biotech…
Germany approves healthcare costs overhaul despite significant pharma opposition
Lawmakers in Germany have passed a bill that will cut health insurance costs in a shakeup that has generated strong resistance from global drugmakers. Germany's Bundestag, the country's primary legislative body and national parliament, gave…
Lakefront Announces Paulo Fontoura has Resigned from its Board following his Appointment as Global Head of R&D at Sanofi
Mechelen, Belgium; July 13, 2026, 22:01 CET; Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT) today announced that following his appointment as Executive Vice President, Global Head of Research & Development Pharma at Sanofi SA, Dr. Paulo…
Rare-Disease Families Can Now Invest In Biotech Gene Therapy
A grandfather playing with his grandson in a wheelchair due to a genetic disability of Pitt-Hopkins syndrome. In drug development, patients are the people a therapy is for. They enroll, they wait, they hope. What they almost never do is own a stake…
Tempus AI: Building Ultimate Healthcare Data Dominance (NASDAQ:TEM)
Tempus AI, Inc. earns a Strong Buy rating due to its transformation into a healthcare data giant with high-margin, rapidly growing data services. TEM's Q1 2026 data segment revenue surged 40% YoY to $87M, with robust bookings and visibility…
United Rentals Q2 Preview: Margin Conversion Is The Next Test (NYSE:URI)
United Rentals (URI) remains rated Hold as Specialty segment margin pressures persist despite strong revenue and industry sentiment. URI's valuation now trades above historical levels, demanding high-quality margin and cash flow improvements to…
Santhera Expands Biomedica Agreement to Extend AGAMREE (Vamorolone) Distribution Across Central Asia and the Caucasus
Pratteln, Switzerland, July 13, 2026 – Santhera Pharmaceuticals (SIX: SANN) today announces an expansion of its exclusive distribution agreement with Biomedica for AGAMREE (vamorolone), extending the partnership to include Georgia…
Psychiatry Lacks Biomarkers. Can This EEG Ballcap Get A Base Hit?
Universal Brain's electroencephalography device is a wearable cap. Universal Brain just announced an FDA 510(k) clearance for its Neurotique™ platform, which offers a five-minute assessment to measure cognitive and emotional brain function…
Quit whining, AOC: Gen Z should THANK Boomers for what they're leaving behind
Alexandria Ocasio-Cortez says she knows why socialism is on the rise: Blame it on the Boomers. “Millennials and Gen Z combined, now for the first time, are eclipsing the number of Baby Boomers,” she explained recently. “Young…
Drug Farm gets $55M, Williams gets $5.3B for power projects from Blackstone-led group
💊 Drug Farm, a Shanghai and Albany, N.Y.-based infection and immunological diseases company, raised $55m in Series D funding led by Shanghai Pudong Leading Area Investment Center and Shanghai Puxing Collaborative Private Equity Fund…
Futures Slide, Oil Surges As Iran War Returns, Chip Stocks Tumble As Korea, SK Hynix Crash
US equity futures are lower on a combination of US/Iran escalation (which is feeding inflationary concerns) and a violent crash in South Korean stocks (which saw SK Hynix plunge by 15% overnight, the most on record, and unironically follows its…
Teva Pharmaceutical Industries Ltd. $TEVA Position Increased by Sequoia Financial Advisors LLC
Sequoia Financial Advisors LLC increased its holdings in shares of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA - Free Report) by 23.0% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange…
Receive a Daily briefing on Pharma Industry News
Get Started